Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
51-200
employees, estimated range
Backers
3
EcoR1 Capital, MPM BioImpact
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Mendra window11-50 employees
Mendra is a venture-backed rare-disease biopharma accelerating the development and commercialization of de-risked breakthrough therapies.
HealxSeries C $47M · 2 yr ago • Founded 2014 • 201-500 employees • 2 roles
Healx is a Cambridge company founded in 2014 that uses artificial intelligence to find treatments for rare diseases. Its knowledge graph…
Addition TherapeuticsVenture round $100M · 9 mo ago • Founded 2021 • 6 roles
We're on a mission to fulfill the promise of genetic medicine for all patients. At Addition, we are advancing a pipeline of therapeutics to…
Epigenic Therapeutics is a frontier biotechnology company dedicated to developing next generation gene modulation therapy utilizing…
AirnaSeries B $155M · 5 mo ago • Founded 2021 • 11-50 employees • 1 role
A bold visionfor genetic medicines AIRNA is committed to delivering the promise of RNA editing to people with rare diseases and common…
AffiniaTX51-200 employees
Affinia Therapeutics is expanding what's possible in adeno-associated virus (AAV) gene therapy today and bringing transformative medicines…

Overview

ReCode is the first genetic medicines platform to enable highly targeted delivery to organs, tissues and cells beyond the liver. Our pipeline of rare disease therapeutics uses optimized mRNA and gene correction with redosing capability.

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Menlo Park
Menlo Park United States
Regional office
Menlo Park, CA
1 open roles 50-200 est. staff
hires for Early Careers
seen since Apr 2024 careers board, company site, job postings